chartexchange

Eisai to Present New Five-Year Lecanemab Data and Real-World Alzheimer's Disease Research at the 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference

JCN Newswire | Nov 1, 2026 8:29 AM EST

Eisai Co., Ltd. announced today that it will present new Alzheimer's disease (AD) research at the 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference, taking place November 16-19, 2026, in Boston and online.

Read original article